Recursion Pharmaceuticals
Nasdaq: RXRXOn BioBridgeX
- Raised $246 million (2020)
- 7 clinical trials, 3 active
- Research grants: $5.8 million
- Founded 2013
Life science companies
Explore 33,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Medical device companies 15,499Biotech companies 7,141Medical device contract manufacturers 5,935Pharmaceutical companies 3,559Diagnostics companies 512Contract sterilization companies 150Contract research organizations 140CDMOs 123Laboratory testing companies 97Research companies 56Life science instrument companies 54
AbbVie Inc.
NYSE: ABBV
- Raised $3.8 billion (2016)
- 1554 clinical trials, 257 active
- FDA-cleared or approved devices
- 10 FDA-registered drug sites
Vericel Corp
Nasdaq: VCEL
- Raised $40 million (2012)
- 14 clinical trials, 2 active
- FDA-cleared or approved devices
- 2 FDA-registered drug sites
GLAUKOS Corp
NYSE: GKOS
- Raised $30 million (2013)
- 67 clinical trials, 11 active
- FDA-cleared or approved devices
- 1 FDA-registered drug site
Mobia Medical, Inc.
Nasdaq: MOBI
- Raised $32 million (2025)
- 7 clinical trials, 2 active
- FDA-cleared or approved devices
- Research grants: $8.3 million
SAB Biotherapeutics, Inc.
Nasdaq: SABS
- Raised $175 million (2025)
- 6 clinical trials, 2 active
- 2 FDA-registered drug sites
- Research grants: $6.1 million
Adaptive Biotechnologies Corp
Nasdaq: ADPT
- Raised $195 million (2015)
- 8 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $5 million
Pulse Biosciences, Inc.
Nasdaq: PLSE
- Raised $50 million (2021)
- 14 clinical trials, 5 active
- FDA-cleared or approved devices
- Research grants: $606,950
Savara Inc
Nasdaq: SVRA
- Raised $27 million (2020)
- 25 clinical trials, 2 active
- 1 FDA-registered drug site
- Research grants: $5 million
Crinetics Pharmaceuticals, Inc.
Nasdaq: CRNX
- Raised $350 million (2024)
- 19 clinical trials, 6 active
- Research grants: $16 million
Artivion, Inc.
NYSE: AORT
- Raised $20 million (2020)
- 22 clinical trials, 4 active
- FDA-cleared or approved devices
- Research grants: $2.4 million
PAVmed Inc.
Nasdaq: PAVM
- Raised $30 million (2026)
- 2 clinical trials
- FDA-cleared or approved devices
- Research grants: $3.6 million
Agilent Technologies
NYSE: AOn BioBridgeX
- FDA-cleared or approved devices
- 2 FDA-registered drug sites
- Research grants: $13,019
Medtronic Inc
- Raised $21 million (2013)
- 141 clinical trials, 16 active
- FDA-cleared or approved devices
- 2 FDA-registered drug sites
Cartesian Therapeutics, Inc.
Nasdaq: RNAC
- Raised $130 million (2024)
- 12 clinical trials, 5 active
- Research grants: $19 million
- Founded 2007
Sintx Technologies, Inc.
Nasdaq: SINT
- Raised $5.5 million (2014)
- 2 clinical trials
- FDA-cleared or approved devices
- Research grants: $7.6 million
Axogen, Inc.
Nasdaq: AXGN
- Raised $1 million (2011)
- 10 clinical trials, 4 active
- FDA-cleared or approved devices
- 1 FDA-registered drug site
Karyopharm Therapeutics Inc.
Nasdaq: KPTI
- Raised $165 million (2022)
- 39 clinical trials, 9 active
- Research grants: $4.4 million
- Founded 2008
Stryker Corp
NYSE: SYK
- Raised $2.9 million (2009)
- 6 clinical trials
- FDA-cleared or approved devices
- 1 FDA-registered drug site
Dare Bioscience, Inc.
Nasdaq: DARE
- Raised $1.7 million (2023)
- 12 clinical trials, 3 active
- Research grants: $14 million
- Founded 2005
Showing 20 of 33,266 companies
Load morePublished company profiles only; counts update daily. Data licences